SHSE:688399 (China)
Â
Class A
Â¥
31.5
-5.21 (-14.19%)
Jul 17
Business Description
Jiangsu Bioperfectus Technologies Co Ltd
ISIN : CNE1000055B2
Share Class Description:
SHSE:688399: Class ATotal Employee Number:
581Compare
Compare
Traded in other countries / regions
688399.China Index Membership
SSE Composite Index IPO Date
2019-12-05Description
Jiangsu Bioperfectus Technologies Co Ltd is engaged in product development, production and sales of disease prevention and control, female genital micro-ecological testing and tumor screening. Its products and solutions involve: HPV & cervical cancer screening, Respiratory infection detection solution, Solutions for infectious diarrhea, STI detection solution for reproductive tract infections, Infectious disease testing, Maternal and child health, Disease prevention and control, Instrument, Scientific research services, and Other.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.24 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | -47.65 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.61 | |||||
Beneish M-Score | -2.86 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -60.1 | |||||
3-Year EBITDA Growth Rate | -75.2 | |||||
3-Year Book Growth Rate | -7.1 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.92 | |||||
9-Day RSI | 46.38 | |||||
14-Day RSI | 45.91 | |||||
3-1 Month Momentum % | -11.47 | |||||
6-1 Month Momentum % | -35.06 | |||||
12-1 Month Momentum % | -7.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.33 | |||||
Quick Ratio | 3.25 | |||||
Cash Ratio | 3.13 | |||||
Days Inventory | 158.63 | |||||
Days Sales Outstanding | 56.24 | |||||
Days Payable | 100.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 7.29 | |||||
3-Year Dividend Growth Rate | -20.5 | |||||
Forward Dividend Yield % | 7.29 | |||||
5-Year Yield-on-Cost % | 7.29 | |||||
3-Year Average Share Buyback Ratio | 1.1 | |||||
Shareholder Yield % | 4.09 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 63.55 | |||||
Operating Margin % | -18.93 | |||||
Net Margin % | -10.05 | |||||
EBITDA Margin % | -3.36 | |||||
FCF Margin % | -21.53 | |||||
OCF Margin % | 7.19 | |||||
ROE % | -1.07 | |||||
ROA % | -0.88 | |||||
ROIC % | -2.77 | |||||
3-Year ROIIC % | -244.11 | |||||
ROC (Joel Greenblatt) % | -1.75 | |||||
ROCE % | -0.34 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 10.72 | |||||
PS Ratio | 11.79 | |||||
PB Ratio | 1.33 | |||||
Price-to-Tangible-Book | 1.34 | |||||
Price-to-Operating-Cash-Flow | 169.35 | |||||
EV-to-EBIT | -250.17 | |||||
EV-to-EBITDA | -250.17 | |||||
EV-to-Revenue | 8.41 | |||||
EV-to-FCF | -39.06 | |||||
Price-to-GF-Value | 1.09 | |||||
Price-to-Projected-FCF | 0.58 | |||||
| Price-to-Net-Current-Asset-Value | 3.62 | |||||
| Price-to-Net-Cash | 4.01 | |||||
Earnings Yield (Greenblatt) % | -0.4 | |||||
FCF Yield % | -1.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jiangsu Bioperfectus Technologies Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 326.023 | ||
| EPS (TTM) (Â¥) | -0.264 | ||
| Beta | 1.1213 | ||
| 3-Year Sharpe Ratio | 0.23 | ||
| 3-Year Sortino Ratio | 0.35 | ||
| Volatility % | 46.86 | ||
| 14-Day RSI | 45.91 | ||
| 14-Day ATR (Â¥) | 2.36995 | ||
| 20-Day SMA (Â¥) | 31.751892 | ||
| 12-1 Month Momentum % | -7.82 | ||
| 52-Week Range (Â¥) | 28.891891 - 68.5 | ||
| Shares Outstanding (Mil) | 124.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jiangsu Bioperfectus Technologies Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jiangsu Bioperfectus Technologies Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| 1.48:1 Stock Split | 2026-07-10 | 30.22 (-0.42%) | ||
| CNY 2.297297 Cash Dividend | 2025-09-11 | 44.05 (+1.72%) | ||
| 1.48:1 Stock Split | 2025-06-13 | 33.77 (-1.22%) |
Show
Entries
Jiangsu Bioperfectus Technologies Co Ltd Frequently Asked Questions
What is Jiangsu Bioperfectus Technologies Co Ltd(SHSE:688399)'s stock price today?
The current price of SHSE:688399 is ¥31.50. The 52 week high of SHSE:688399 is ¥68.50 and 52 week low is ¥28.89.
When is next earnings date of Jiangsu Bioperfectus Technologies Co Ltd(SHSE:688399)?
The next earnings date of Jiangsu Bioperfectus Technologies Co Ltd(SHSE:688399) is .
Does Jiangsu Bioperfectus Technologies Co Ltd(SHSE:688399) pay dividends? If so, how much?
The Dividend Yield %  of Jiangsu Bioperfectus Technologies Co Ltd(SHSE:688399) is 7.29% (As of Today), Highest Dividend Payout Ratio of Jiangsu Bioperfectus Technologies Co Ltd(SHSE:688399) was 0.33. The lowest was 0.23. And the median was 0.28. The  Forward Dividend Yield % of Jiangsu Bioperfectus Technologies Co Ltd(SHSE:688399) is 7.29%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Jiangsu Bioperfectus Technologies Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers